Renaissance Technologies’s CureVac CVAC Stock Holding History

Renaissance Technologies’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-99,348	Closed	-$783K	–	4154
2022 Q3	$783K	Buy	+99,348	New	+$1.16M	﹤0.01%	2647

Other funds holding CVAC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's CVAC Position: Q4 2022 in Review

Renaissance Technologies sold out of CureVac (CVAC) in Q4 2022, closing a stake of 99,348 shares — an estimated $783K sold.

Renaissance Technologies first reported a position in CVAC in Q3 2022 and held it in 1 quarter. The position peaked at $783K in Q3 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

Renaissance Technologies reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
Renaissance Technologies sold 99,348 CureVac shares in Q4 2022, an estimated $783K.
Renaissance Technologies first reported a position in CureVac in Q3 2022 and held it in 1 quarter.
Renaissance Technologies's CureVac position peaked at $783K in Q3 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.